ReWalk Robotics

ReWalk Robotics Ltd. Is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Yokneam Ilit, Israel.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries

ReWalk Robotics Reports Third Quarter 2022 Financial Results

MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time.

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

MARLBOROUGH, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”, or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, is announcing that the Company will begin submitting Medicare cases following CMS's September 26, 2022, announcement affirming that the MACs have discretion to cover and reimburse for the ReWalk exoskeleton. ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.

ReWalk Takes Another Step Toward Medicare Coverage

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social Court has scheduled a hearing to review the decision of whether an exoskeleton medical device should be classified as directly or indirectly compensating for the lost function of individuals with spinal cord injuries or paraplegia. The hearing is scheduled for November 10, 2022.

German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

Brings Significant Experience in M&A, Investor Relations, and Financial Strategy Brings Significant Experience in M&A, Investor Relations, and Financial Strategy

ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Almog Adar - Director of Finance Larry Jasinski - CEO Conference Call Participants Swayampakula Ramakanth - H.C.

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q2 2022 Results - Earnings Call Transcript

ReWalk (RWLK) delivered earnings and revenue surprises of -75% and 32.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q2 Loss, Misses Revenue Estimates

Highlights June 8 th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device

ReWalk Robotics Reports Second Quarter 2022 Financial Results

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's 2022 Annual Meeting of Shareholders (the “Annual Meeting”) based on the final tabulation of votes certified by an independent Inspector of Elections. At the Annual Meeting, shareholders voted to reelect Chief Executive Officer Larry Jasinski, Dr. John William Poduska and Randel Richner to the Board of Directors (the “Board”). Shareholders did not vote to approve the proposals put forth by Creative Value Capital Limited Partnership (“CVC”).

ReWalk Robotics Announces Results of 2022 Annual Meeting

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli court approval to repurchase up to $8 million of its Ordinary Shares, par value NIS 0.25 per share. The court approval is valid through January 20, 2023.

ReWalk Receives Court Approval for Share Repurchase Program

21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal Exoskeleton 21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal Exoskeleton

100th ReWalk Exoskeleton Supplied in Germany

MARLBOROUGH, Mass. & BERLIN & YOKNEAM ILIT, Israel--(BUSINESS WIRE)--ReWalk Robotics Ltd. (Nasdaq: RWLK), (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today provided notice that the 2022 Annual Meeting of Shareholders (the “Meeting”) will be held on Wednesday, July 27, 2022, at 10:00 a.m. EDT at the Hyatt Place Marlborough / Apex Center Hotel in Marlborough, Massachusetts. TO THE SHAREHOLDERS OF REWALK ROBOTICS L

ReWalk Provides Notice of 2022 Annual Meeting of Shareholders

CytoSorbents

Standard BioTools Inc

Sunshine Biopharma

Troika Media Group

Insiders are buying these penny stocks. The post 10 Top Penny Stocks To Buy In June According To These Insiders Part 1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

10 Top Penny Stocks To Buy In June According To These Insiders Part 1

Highlights the Company's Recent Progress and Momentum Towards Value-Enhancing Commercialization and Reimbursement

ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders

Shareholders Are Not Required to Take Action at This Time

ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital

ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q1 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Almog Adar - Director of Finance Larry Jasinski - CEO Conference Call Participants Martin Pollack - KMTR Holdings Operator Good day, and thank you for standing by.

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q1 2022 Results - Earnings Call Transcript

ReWalk (RWLK) delivered earnings and revenue surprises of -40% and 60.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates

CMS Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda includes the ReWalk Exoskeleton CMS Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda includes the ReWalk Exoskeleton

ReWalk Robotics Reports First Quarter 2022 Financial Results

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2022 financial results on Friday, May 13, 2022, after the U.S. financial markets close.

ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022

The MAGNET Consortium program led by Israel's Innovation Authority fosters collaboration through R&D grants The MAGNET Consortium program led by Israel's Innovation Authority fosters collaboration through R&D grants

ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction

Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development

ReWalk Robotics Announces the Appointment of Joseph E. Turk, Jr. to their Board of Directors

Simon Kindleysides is first paralyzed man to climb a 51-story skyscraper; earns his second Guinness World Record using his ReWalk Personal Exoskeleton Simon Kindleysides is first paralyzed man to climb a 51-story skyscraper; earns his second Guinness World Record using his ReWalk Personal Exoskeleton

ReWalker Sets Guinness World Record for Climbing a London Skyscraper While Wearing an Exoskeleton

ReWalk just barely met its 2021 revenue targets at $6 million for the year, but was still dealing with Covid-19 restrictions impacting the sales process for much of the year.

ReWalk Robotics: Catalysts On The Horizon

ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q4 2021 Results - Earnings Call Transcript

News for ReWalk Robotics Stock (RWLK)